Alcohol Use in Patients with Chronic Liver Disease | New England Journal of Medicine Skip to
main content The New England Journal of Medicine homepage Advanced Search SEARCH …

Baclofen is the only drug that has been investigated in randomized controlled studies for anti-
craving in patients with alcohol use disorder (AUD) and liver disease. However, the results …

Hazardous alcohol use is associated with detrimental health outcomes among persons
living with HIV (PLWH). We examined the prevalence and factors associated with hazardous …

Alcohol use disorder (AUD) and hepatitis C virus (HCV) infection frequently co-occur. AUD is
associated with greater exposure to HCV infection, increased HCV infection persistence …

Background: In 2007, a survey in Rawalpindi found the prevalence of hepatitis C virus
(HCV) in injecting drug users (IDUs) to be low (17%), despite widespread needle/syringe …

BACKGROUND: Co-infection with hepatitis C virus (HCV) is common among HIV-infected
women. OBJECTIVE: To our further understanding of the risk factors for HCV viremia and the …

Background When shared by people who inject drugs, needles and syringes with different
dead space may affect the probability of HIV and hepatitis C virus (HCV) transmission …

Improved understanding of natural history of hepatitis C virus (HCV) RNA levels in chronic
infection provides enhanced insights into immunopathogenesis of HCV and has implications …

Hepatitis C virus (HCV) treatment failure and disease progression are more likely with high
HCV‐RNA load. Correlates of high HCV‐RNA load in individuals with haemophilia are …

BACKGROUND: Chronic hepatitis C (HCV) infection, defined as persistent RNA (viral load)
for at least 6 months, accounts for up to 50% of all cirrhosis, end-stage liver disease and liver …